Dr. Mithu Maheswaranathan
Dr. Mithu Maheswaranathan talks about the findings of a study which assessed obinutuzumab for patients with active lupus. Researchers sought to better address the gap in knowledge on acetaminophen safety in patients with osteoarthritis. Dr. Mithu Maheswaranathan discusses the link between vitamin D levels and pregnancy outcomes in women with lupus. A study sought to understand the use of herbal supplement treatment in adult patients with autoimmune skin diseases. The role of dietary and lifestyle interventions in the management of rheumatic disease is poorly understood. Dr. Mithu Maheswaranathan on a study that shows metformin is a promising complementary therapy for SLE. A study assessed glucocorticoid regimens on renal response, infections, and mortality in patients with lupus nephritis. There is increasing interest in the use of musculoskeletal ultrasound in pediatric rheumatology. A study analyzed the use of after-visit instructions at rheumatology clinics. It is critical for physicians to be confident and comfortable in diagnosing and managing knee osteoarthritis. Mithu Maheswaranathan, MD, spoke about challenges, treatments, and trends in rheumatology, as well as upcoming advancements. A study aimed to create a benefit-versus-harm shared decision-making tool for hydroxychloroquine for patients with SLE. A study provided a unique characterization of a rare: large-vessel involvement from ANCA-associated vasculitis. A study sought to identify variables distinguishing inflammatory from noninflammatory arthritis in a large cohort. Ultra-low dose rituximab significantly reduced the rate of infections versus the standard low dosage in rheumatoid arthritis. Researchers examined changes in objective measures of cardiorespiratory function and patient-reported outcomes in lupus. A study sought to characterize racial differences in lupus clinical manifestations. VEXAS (vacuoles, E1-ubiquitin-activating enzyme, X-linked, autoinflammatory, somatic) syndrome is a newly discovered ... Two recent studies presented at the American College of Rheumatology (ACR) Convergence 2022 conference evaluated ANA ... It has been well demonstrated that patients with systemic autoimmune rheumatic diseases (SARDs) are at higher risk of ...